Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
CGX1321
i
Other names:
CGX1321, CGX-1321, CGX 1321
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Curegenix
Drug class:
Wnt signalling pathway inhibitor, PORCN inhibitor
Related drugs:
‹
PRI724 (5)
WNT974 (2)
SM04690 (2)
BC2059 (2)
NCB-0846 (1)
XAV-939 (1)
OMP-18R5 (1)
CWP291 (0)
Circ0003039 (0)
E7386 (0)
KY1022 (0)
OMP-54F28 (0)
OTSA101-DTPA-90Y (0)
ETC-159 (0)
RXC004 (0)
PRI724 (5)
WNT974 (2)
SM04690 (2)
BC2059 (2)
NCB-0846 (1)
XAV-939 (1)
OMP-18R5 (1)
CWP291 (0)
Circ0003039 (0)
E7386 (0)
KY1022 (0)
OMP-54F28 (0)
OTSA101-DTPA-90Y (0)
ETC-159 (0)
RXC004 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
RSPO3 fusion
Gastric Cancer
RSPO3 fusion
Gastric Cancer
pembrolizumab + CGX1321
Sensitive: C3 – Early Trials
pembrolizumab + CGX1321
Sensitive
:
C3
pembrolizumab + CGX1321
Sensitive: C3 – Early Trials
pembrolizumab + CGX1321
Sensitive
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login